Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 35:3;O2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003390 AN005564 In-depth profiling of biosignatures for Type 2 diabetes mellitus cohort utilizing an integrated targeted LC-MS platform Blood Human Diabetes First Affiliated Hospital of Dalian Medical University LC-MS
ST003349 AN005490 An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - targeted Blood Human First Affiliated Hospital of Dalian Medical University LC-MS
ST002414 AN003935 Mass spectrometry dataset of LC-MS Lipidomics Analysis of Xenopus Laevis Optic Nerve Eye tissue Frog Eye disease University of Miami LC-MS
ST002398 AN003905 Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue Muscle Zebrafish Myopathy University of North Carolina at Chapel Hill LC-MS
ST001725 AN002810 Lipidomics dataset of Danio rerio optic nerve regeneration model Eye tissue Zebrafish Eye disease University of Miami LC-MS
  logo